Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Prothena Corp
PRTA
$425M
| $10.8M | 0.01% |
151,669
+63,725
| +72% | +$3.96M |
|
1927
Halozyme
HALO
$9.68B
| $10.8M | 0.01% |
265,273
+49,650
| +23% | +$2.08M |
|
1928
PUT
Stanley Black & Decker
SWK
$14.3B
| $10.8M | 0.01% |
+61,500
| New | +$12M |
|
1929
CALL
GE Aerospace
GE
$368B
| $10.8M | 0.01% |
2,941,975
+2,578,361
| +709% | +$166M |
|
1930
Lincoln National
LNC
$8.77B
| $10.8M | 0.01% |
156,465
+89,106
| +132% | +$5.82M |
|
1931
PUT
Equinix
EQIX
$101B
| $10.7M | 0.01% |
+13,600
| New | +$11.3M |
|
1932
Porch Group
PRCH
$1.59B
| $10.7M | 0.01% |
607,389
+395,019
| +186% | +$7.41M |
|
1933
ICU Medical
ICUI
$4.17B
| $10.7M | 0.01% |
45,959
-2,878
| -6% | -$604K |
|
1934
MacroGenics
MGNX
$231M
| $10.7M | 0.01% |
512,049
+29,720
| +6% | +$716K |
|
|
TWOA
1935
DELISTED
two
TWOA
| $10.7M | 0.01% |
1,094,572
-39,583
| -3% | -$387K |
|
1936
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.52B
| $10.7M | 0.01% |
240,872
+46,228
| +24% | +$2.15M |
|
1937
Sarepta Therapeutics
SRPT
$1.59B
| $10.7M | 0.01% |
115,652
+48,062
| +71% | +$3.7M |
|
|
SWET
1938
DELISTED
Athlon Acquisition Corp. Class A Common stock
SWET
| $10.7M | 0.01% |
1,093,547
+16,755
| +2% | +$162K |
|
|
OPA
1939
DELISTED
Magnum Opus Acquisition Limited
OPA
| $10.7M | 0.01% |
1,079,872
+748,674
| +226% | +$7.3M |
|
1940
Par Pacific Holdings
PARR
$4.26B
| $10.7M | 0.01% |
679,291
+223,958
| +49% | +$3.47M |
|
|
VSTO
1941
DELISTED
Vista Outdoor Inc.
VSTO
| $10.7M | 0.01% |
264,803
+213,150
| +413% | +$8.78M |
|
1942
Quest Diagnostics
DGX
$25.8B
| $10.7M | 0.01% |
73,399
-158,043
| -68% | -$23.1M |
|
1943
Otter Tail
OTTR
$3.74B
| $10.7M | 0.01% |
190,507
+46,373
| +32% | +$2.46M |
|
1944
Nucor
NUE
$58.8B
| $10.7M | 0.01% |
108,240
-10,072
| -9% | -$1.07M |
|
1945
Stevanato
STVN
$5.45B
| $10.6M | 0.01% |
+420,434
| New | +$9.9M |
|
|
FRXB
1946
DELISTED
Forest Road Acquisition Corp. II
FRXB
| $10.6M | 0.01% |
1,090,359
+822,550
| +307% | +$8M |
|
1947
CALL
American Airlines Group
AAL
$10.1B
| $10.6M | 0.01% |
517,900
+300,000
| +138% | +$6.08M |
|
1948
PubMatic
PUBM
$581M
| $10.6M | 0.01% |
403,074
+312,471
| +345% | +$9.37M |
|
1949
Kinsale Capital Group
KNSL
$8.13B
| $10.6M | 0.01% |
65,674
-11,400
| -15% | -$1.98M |
|
|
MACQ
1950
DELISTED
MCAP Acquisition Corporation Class A Common Stock
MACQ
| $10.6M | 0.01% |
1,074,728
+767,507
| +250% | +$7.51M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.